Literature DB >> 24577180

Posterior reversible encephalopathy syndrome (PRES) in a patient with late postpartum eclampsia.

Jharendra P Rijal1, Smith Giri, Suvash Dawadi, Khagendra V Dahal.   

Abstract

Posterior reversible encephalopathy syndrome (PRES) is a reversible neurological entity characterised by seizure, headaches, visual symptoms, impaired consciousness and other focal neurological findings. It is caused by a wide variety of causes ultimately leading to a vasogenic cerebral oedema of occipital and parietal lobes of the brain. We present here a young woman with headache, generalised tonic-clonic seizures and cortical blindness in a late postpartum stage. Reversibility of the symptoms and characteristic imaging findings led us to a diagnosis of PRES in our patient.

Entities:  

Mesh:

Year:  2014        PMID: 24577180      PMCID: PMC3939391          DOI: 10.1136/bcr-2013-203162

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  25 in total

Review 1.  Posterior reversible encephalopathy syndrome in intensive care medicine.

Authors:  Giuseppe Servillo; Francesca Bifulco; Edoardo De Robertis; Ornella Piazza; Pasquale Striano; Fabio Tortora; Salvatore Striano; Rosalba Tufano
Journal:  Intensive Care Med       Date:  2006-11-21       Impact factor: 17.440

2.  Posterior leukoencephalopathy without severe hypertension: utility of diffusion-weighted MRI.

Authors:  H Ay; F S Buonanno; P W Schaefer; D A Le; B Wang; R G Gonzalez; W J Koroshetz
Journal:  Neurology       Date:  1998-11       Impact factor: 9.910

3.  PRES: posterior or potentially reversible encephalopathy syndrome?

Authors:  M C Narbone; R Musolino; F Granata; I Mazzù; M Abbate; E Ferlazzo
Journal:  Neurol Sci       Date:  2006-07       Impact factor: 3.307

4.  Posterior reversible encephalopathy syndrome in children: its high prevalence and more extensive imaging findings.

Authors:  Kenji Ishikura; Masahiro Ikeda; Yuko Hamasaki; Hiroshi Hataya; Seiichirou Shishido; Hiroshi Asanuma; Gen Nishimura; Ryugo Hiramoto; Masataka Honda
Journal:  Am J Kidney Dis       Date:  2006-08       Impact factor: 8.860

5.  Cyclosporine neurotoxicity and its relationship to hypertensive encephalopathy: CT and MR findings in 16 cases.

Authors:  R B Schwartz; S M Bravo; R A Klufas; L Hsu; P D Barnes; C D Robson; J H Antin
Journal:  AJR Am J Roentgenol       Date:  1995-09       Impact factor: 3.959

6.  Status epilepticus as initial manifestation of posterior reversible encephalopathy syndrome.

Authors:  O S Kozak; E F M Wijdicks; E M Manno; J T Miley; A A Rabinstein
Journal:  Neurology       Date:  2007-08-28       Impact factor: 9.910

7.  A reversible posterior leukoencephalopathy syndrome.

Authors:  J Hinchey; C Chaves; B Appignani; J Breen; L Pao; A Wang; M S Pessin; C Lamy; J L Mas; L R Caplan
Journal:  N Engl J Med       Date:  1996-02-22       Impact factor: 91.245

8.  Postpartum blindness: two cases.

Authors:  Kimberly A Chambers; Terry Wayne Cain
Journal:  Ann Emerg Med       Date:  2004-02       Impact factor: 5.721

9.  Posterior reversible encephalopathy syndrome (PRES) in critically ill obstetric patients.

Authors:  Giuseppe Servillo; Pasquale Striano; Salvatore Striano; Fabio Tortora; Patrizia Boccella; Edoardo De Robertis; Flavia Rossano; Francesco Briganti; Rosalba Tufano
Journal:  Intensive Care Med       Date:  2003-08-06       Impact factor: 17.440

10.  Delayed postpartum preeclampsia: an experience of 151 cases.

Authors:  Laura A Matthys; Kristin H Coppage; Donna S Lambers; John R Barton; Baha M Sibai
Journal:  Am J Obstet Gynecol       Date:  2004-05       Impact factor: 8.661

View more
  2 in total

1.  A Case Report of Severe Posterior Reversible Encephalopathy Syndrome Due to Accelerated Hypertension in a Young Patient.

Authors:  Suhrim Choe; Nagapratap Ganta; Dina Alnabwani; Sharon Hechter; Ghadier Alsaoudi; Vraj Patel; Ankita Prasad; Pramil Cheriyath
Journal:  Cureus       Date:  2022-07-16

2.  Posterior reversible encephalopathy syndrome after postpartum hemorrhage and uterine artery embolization: A case report.

Authors:  Fangfang Shi; Liwei Shen; Yonghui Shi; Lei Shi; Xiaoli Yang; Zhi Jin; Wenpeng Liu; Danhong Wu
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.